Terns Pharmaceuticals (TERN) Operating Expenses (2020 - 2022)
Historic Operating Expenses for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to $16.8 million.
- Terns Pharmaceuticals' Operating Expenses rose 1310.66% to $16.8 million in Q4 2022 from the same period last year, while for Sep 2023 it was $16.8 million, marking a year-over-year decrease of 7199.02%. This contributed to the annual value of $101.9 million for FY2024, which is 66.99% down from last year.
- Latest data reveals that Terns Pharmaceuticals reported Operating Expenses of $16.8 million as of Q4 2022, which was up 1310.66% from $17.3 million recorded in Q3 2022.
- In the past 5 years, Terns Pharmaceuticals' Operating Expenses registered a high of $17.3 million during Q3 2022, and its lowest value of $8.7 million during Q3 2020.
- In the last 3 years, Terns Pharmaceuticals' Operating Expenses had a median value of $12.6 million in 2021 and averaged $12.5 million.
- Per our database at Business Quant, Terns Pharmaceuticals' Operating Expenses soared by 6968.52% in 2021 and then soared by 397.86% in 2022.
- Terns Pharmaceuticals' Operating Expenses (Quarter) stood at $8.8 million in 2020, then surged by 69.69% to $14.9 million in 2021, then grew by 13.11% to $16.8 million in 2022.
- Its last three reported values are $16.8 million in Q4 2022, $17.3 million for Q3 2022, and $14.1 million during Q2 2022.